Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. E.G.E. (Elisabeth) de Vries

Publicaties

Automated Whole-Body PET/CT Lesion Tracking for Lesion-Wise Response Evaluation in Metastatic Breast Cancer

Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

Demystifying the WHO Model Lists of Essential Medicines for cancer care

Dose optimisation to improve access to effective cancer medicines

ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

Heterogeneity of CD8 T-Cell Changes in Advanced Melanomas After Initiation of Immunotherapy

Impact of CMV Infection and Cancer Treatment on Vaccine Efficacy in Oncology Patients

Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial

Intrapatient 16α-[18F]Fluoro-17β-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.

Pers/media

FORESIGHT doet onderzoek naar juiste patiënt en passende therapie

Major funding boost for molecular imaging in drug development

New consortium for immunotherapy research

FORESIGHT consortium encourages molecular imaging in developing new drugs

FORESIGHT consortium secures €9 million to fast-track drug development

Inschrijving 30e Oncologiedagen geopend

Van Laarhoven nieuw lid raad van toezicht IKNL

Whole-Body PET Scans Highlight Complexity of Immunotherapy Response